Grace Therapeutics, Inc. ($GRCE)
Filing Information
| Accession Number | 0001493152-26-048591 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 26, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
87,801
Total Value
$158,600.87
P&L
+0.2% (+$318.94)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock, par value $0.0001 per share | โ | Oct 22, 2026 | Purchase | 21,390 | $1.93 | $41,192.86 | 2,970,000 | Indirect | By Opaleye, L.P. | View Details | |
10% Owner | Common Stock, par value $0.0001 per share | โ | Oct 26, 2026 | Purchase | 66,411 | $1.77 | $117,408.01 | 3,036,411 | Indirect | By Opaleye, L.P. | View Details |